Cargando…

R. Daniel Beauchamp (1946–2022)

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947392/
https://www.ncbi.nlm.nih.gov/pubmed/36846193
http://dx.doi.org/10.1016/j.omto.2023.01.004
_version_ 1784892542876123136
collection PubMed
description
format Online
Article
Text
id pubmed-9947392
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society of Gene & Cell Therapy
record_format MEDLINE/PubMed
spelling pubmed-99473922023-02-24 R. Daniel Beauchamp (1946–2022) Mol Ther Oncolytics Editorial American Society of Gene & Cell Therapy 2023-02-10 /pmc/articles/PMC9947392/ /pubmed/36846193 http://dx.doi.org/10.1016/j.omto.2023.01.004 Text en © 2023. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
R. Daniel Beauchamp (1946–2022)
title R. Daniel Beauchamp (1946–2022)
title_full R. Daniel Beauchamp (1946–2022)
title_fullStr R. Daniel Beauchamp (1946–2022)
title_full_unstemmed R. Daniel Beauchamp (1946–2022)
title_short R. Daniel Beauchamp (1946–2022)
title_sort r. daniel beauchamp (1946–2022)
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947392/
https://www.ncbi.nlm.nih.gov/pubmed/36846193
http://dx.doi.org/10.1016/j.omto.2023.01.004